Timothy Springer

$1.05 B

Ranked #3266 in World

About Timothy Springer

Immunologist Timothy "Tim" A. Springer, a distinguished Harvard Medical School professor, has made pioneering contributions to immunology, including discovering key cell adhesion molecules. His research on integrins, immune system functions, and pathologies has propelled him to senior positions at Boston institutions and led to founding innovative biotech ventures such as Moderna. Springer's influence extends beyond science through philanthropy and honors, including the esteemed Albert Lasker Award in 2022.

Born

February 23, 1948 in Fort Benning, Georgia

Age

78 years

Source Of Wealth

Biotech

Industries

Healthcare

Citizenship

United States

Residence

Chestnut Hill, Massachusetts

Education

Ph.D, Harvard University; Bachelor of Science, University of California, Berkeley

Timothy "Tim" A. Springer was born in 1948 in Fort Benning, Georgia. His early years and childhood were spent in a military environment, as his father was a career Army officer.

Timothy Springer: Family

Springer is married to Chafen Lu, a former assistant professor at Harvard Medical School. They have five children, three from his first marriage.

Timothy Springer: Career Highlights

Springer's career highlights include his groundbreaking research on integrins and intercellular adhesion molecules (ICAMs), which led to a deeper understanding of the immune system. He has also made significant contributions to the fields of malaria, transforming growth factor beta (TGF-β) signaling, and von Willebrand factor.

Timothy Springer: Companies

Springer has been involved in several business ventures throughout his career. He founded LeukoSite in 1993, which was later acquired by Millennium Pharmaceuticals in 1998. He co-founded Scholar Rock in 2012 and Morphic Therapeutic in 2015. Springer was also an early investor in Selecta Biosciences and Editas Medicine, and a founding investor of Moderna, where he made a significant return on his investment.

Timothy Springer: Major Achievements

Springer's major achievements include the discovery of the first integrins, LFA-1, and intercellular adhesion molecules (ICAMs), and elucidating their function in the immune system. His research has had a profound impact on our understanding of immunology and has led to the development of new treatments for various diseases.

Timothy Springer: Awards & Achievements

Springer has received numerous awards and honors for his contributions to science and medicine. These include the American Heart Association Basic Research Prize, the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, the Crafoord Prize in Polyarthritis, the Guggenheim Fellowship, the Henry M. Stratton Medal, the Canada Gairdner International Award, the Albert Lasker Award for Basic Medical Research, and the Robert Koch Prize.

Timothy Springer: Personal Life & Legacy

Springer is a gongshi collector and has made significant contributions to the field of biomedical research.

He founded and contributed to the Institute for Protein Innovation, a Boston-based nonprofit biomedical research organization. Springer has also endowed professorships at Harvard Medical School, Boston Children's Hospital, and Berkeley.

Timothy Springer: Trivia

Springer made a significant investment in Moderna, which paid off handsomely when the company launched its initial public offering (IPO) in 2018. He is the fourth-largest shareholder of Moderna and made an estimated USD$400 million from the IPO. During the COVID-19 pandemic, Springer's net worth was estimated to be around USD$1 billion.

Wealth History

Timeline

1948

Timothy "Tim" A. Springer was born in Fort Benning, Georgia.

1981-1988

Chief of the Laboratory of Membrane Immunochemistry at the Dana Farber Cancer Institute.

1983

Promoted to associate professor at Harvard Medical School.

1988-2012

Senior Investigator at the Immune Disease Institute of Boston.

1989

Appointed Latham Family Professor at Harvard Medical School.

1993

Founded LeukoSite (acquired by Millennium Pharmaceuticals in 1998).

1993

American Heart Association Basic Research Prize.

1995

William B. Coley Award for Distinguished Research in Basic and Tumor Immunology.

1996

Elected to the National Academy of Sciences.

2001

Elected as a Fellow of the American Academy of Arts and Sciences.

2004

Crafoord Prize in Polyarthritis.

2004

Guggenheim Fellowship.

2010

Invested USD$5 million in Moderna, becoming a founding investor.

2012

Senior Investigator at the Research Program in Cellular and Molecular Medicine of the Boston Children's Hospital (since 2012).

2012

Co-founded Scholar Rock.

2013

Elected as a Fellow of the American Association for the Advancement of Science.

2014

AAI-Life Technologies Meritorious Career Award (now AAI-Thermo Fisher Meritorious Career Award), American Association of Immunologists.

2014

Henry M. Stratton Medal, American Society of Hematology.

2015

Co-founded Morphic Therapeutic.

2018

Made USD$400 million when Moderna launched its initial public offering (IPO).

2019

Canada Gairdner International Award.

2022

Albert Lasker Award for Basic Medical Research.

2023

Robert Koch Prize.

Timothy Springer : FAQs

What is Timothy Springer's current net worth?

Timothy Springer's current net worth is $1.05 billion.

What is Timothy Springer's current global rank among billionaires?

Timothy Springer holds the 3266th position globally among billionaires.

What is Timothy Springer's current ranking within the United States?

Timothy Springer holds the 945th position in United States.

What was the change in Timothy Springer's net worth compared to the previous year?

Timothy Springer's net worth increased by 78.94 million dollars compared to the previous year 2025, when his net worth was 0.97 billion dollars.

What is the recent change in Timothy Springer's net worth?

Timothy Springer's net worth decreased by 12.7 million dollars recently, a 1.21% decrease, with his net worth standing at 1.05 billion dollars.

What are Timothy Springer's main sources of wealth?

Timothy Springer's main source of income comes from Biotech.

In which industry does Timothy Springer primarily operate?

Timothy Springer is primarily involved in the Healthcare industry.

What is Timothy Springer educational background?

Timothy Springer holds a Ph.D from Harvard University and a Bachelor of Science from the University of California from Berkeley.

How old is Timothy Springer?

Timothy Springer is 78 years old.

Who is Timothy A. Springer and what are his significant scientific contributions?

Timothy A. Springer, born in 1948, is an immunologist and the Latham Family Professor at Harvard Medical School. He is renowned for discovering the first integrins, such as LFA-1, and intercellular adhesion molecules (ICAMs), and for elucidating their function in the immune system. His research interests also include malaria, TGF-β signaling, and von Willebrand factor.

What notable positions has Tim Springer held throughout his career?

Tim Springer has had a distinguished career, including a postdoctoral position under César Milstein, becoming an assistant professor and later an associate professor at Harvard Medical School, and serving as Chief of the Laboratory of Membrane Immunochemistry at the Dana Farber Cancer Institute. He also became a Senior Investigator at the Immune Disease Institute and currently holds a position at the Boston Children's Hospital's Research Program in Cellular and Molecular Medicine.

What business ventures has Timothy A. Springer been involved in?

Timothy A. Springer has been a prolific entrepreneur, having founded LeukoSite in 1993, Scholar Rock in 2012, and Morphic Therapeutic in 2015. He was also an early investor in Selecta Biosciences and Editas Medicine, and a founding investor of Moderna, where he was the fourth-largest shareholder and made USD$400 million during its IPO in 2018.

Can you highlight Timothy Springer's family and philanthropic activities?

Tim Springer is married to Chafen Lu and has five children. He is a gongshi collector and has founded the Institute for Protein Innovation. Furthermore, he has made philanthropic contributions to the field of science, by endowing professorships at various institutions including Harvard Medical School and Boston Children's Hospital.

What are some of the awards and honors received by immunologist Timothy A. Springer?

Timothy A. Springer has won numerous prestigious awards, including the American Heart Association Basic Research Prize, the William B. Coley Award, and the Albert Lasker Award for Basic Medical Research. He is also a member of the National Academy of Sciences and has received the Guggenheim Fellowship, Canada Gairdner International Award, and most recently, the Robert Koch Prize in 2023.